Cândida Fonseca

2000–2026 年に発表

別表記
Candida Fonseca
45
論文数
18,117
被引用数
31
h 指数
43
i10 指数

被引用数

Cândida Fonseca の年別被引用数1997 年: 被引用 1 件2003 年: 被引用 1 件2004 年: 被引用 8 件2005 年: 被引用 7 件2006 年: 被引用 4 件2007 年: 被引用 4 件2008 年: 被引用 23 件2009 年: 被引用 34 件2010 年: 被引用 33 件2011 年: 被引用 22 件2012 年: 被引用 79 件2013 年: 被引用 249 件2014 年: 被引用 278 件2015 年: 被引用 284 件2016 年: 被引用 286 件2017 年: 被引用 177 件2018 年: 被引用 110 件2019 年: 被引用 431 件2020 年: 被引用 431 件2021 年: 被引用 433 件2022 年: 被引用 311 件2023 年: 被引用 218 件2024 年: 被引用 397 件2025 年: 被引用 300 件2026 年: 被引用 21 件1998〜2002 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,268 件、この内訳の 14%イギリス: 引用元論文 747 件、この内訳の 8.2%イタリア: 引用元論文 675 件、この内訳の 7.4%ドイツ: 引用元論文 601 件、この内訳の 6.6%オランダ: 引用元論文 469 件、この内訳の 5.2%フランス: 引用元論文 444 件、この内訳の 4.9%カナダ: 引用元論文 347 件、この内訳の 3.8%スウェーデン: 引用元論文 334 件、この内訳の 3.7%スペイン: 引用元論文 311 件、この内訳の 3.4%中国: 引用元論文 259 件、この内訳の 2.8%ポーランド: 引用元論文 234 件、この内訳の 2.6%スイス: 引用元論文 229 件、この内訳の 2.5%
0%14%その他 34.9%

分野

  • Medicine89.8%
  • Biochemistry, Genetics and Molecular Biology4.2%
  • Engineering1.8%
  • Immunology and Microbiology1.2%
  • Nursing0.6%
  • Computer Science0.5%
  • その他1.9%

トピック

  • Heart Failure Treatment and Management17.4%
  • Cardiovascular Function and Risk Factors11.1%
  • Cardiac pacing and defibrillation studies4.1%
  • Diabetes Treatment and Management3.1%
  • Lipoproteins and Cardiovascular Health2%
  • Cardiac Fibrosis and Remodeling1.8%
  • その他60.5%

共著者

全論文

検索で開く
  1. Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gustavs Latkovskis, Alex Pui‐Wai Lee, Gerard C.M. Linssen, Guillermo Llamas-Esperón, Vyacheslav Mareev, Felipe A. Martínez, Vojtěch Melenovský, Béla Merkely, Savina Nodari, Mark C. Petrie, Clara Saldarriaga, José Francisco Kerr Saraiva, Naoki Sato, Morten Schou, Kavita Sharma, Richard W. Troughton, Jacob A. Udell, Heikki Ukkonen, Orly Vardeny, Subodh Verma, Dirk von Lewinski, Л. Г. Воронков, Mehmet Birhan Yılmaz, Shelley Zieroth, James Lay‐Flurrie, Ilse van Gameren, Flaviana Amarante, Peter Kolkhof, Prabhakar Viswanathan - New England Journal of Medicine 2024 被引用: 709

  2. Epidemiology and One-Year Outcomes in Patients With Chronic Heart Failure and Preserved, Mid-Range and Reduced Ejection Fraction: An Analysis of The ESC Heart Failure Long-Term Registry

    著者: , , , , , , , , , , , , , , , , , - European Journal of Heart Failure 2017 被引用: 904

  3. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , V. Dean, Christi Deaton, Robert Fagard, Christian Funck‐Brentano, David Hasdai, Arno W. Hoes, Paulus Kirchhof, Juhani Knuuti, Philippe Kolh, Theresa A. McDonagh, Bruno Moulin, Bogdan A. Popescu, Željko Reiner, Udo Sechtem, P. A. Sirnes, Michał Tendera, Adam Torbicki, Alec Vahanian, Stephan Windecker, Document Reviewers, Theresa A. McDonagh, Udo Sechtem, Luis Almenar Bonet, Panayiotis Avraamides, Hisham A. Ben Lamin, Michele Brignole, António Coca, Peter J. Cowburn, Henry Dargie, Perry Elliott, Frank A. Flachskampf, Giuseppe Guida, S Hardman, Bernard Iung, Béla Merkely, Christian Mueller, J. Nanas, Olav Wendelboe Nielsen, Stein Ørn, John Parissis, Piotr Ponikowski - European Heart Journal 2012 被引用: 6,906

  4. Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alexander Parkhomenko, Piotr Ponikowski, Félix José Alvarez Ramires, Pranas Šerpytis, Karen Sliwa, Jindřich Špinar, Thomas Suter, János Tomcsányi, Hans Vandekerckhove, Dragoş Vinereanu, Adriaan A. Voors, Mehmet Birhan Yılmaz, Faı̈ez Zannad, Lucie Sharpsten, Jason C. Legg, Claire Varin, Narimon Honarpour, Siddique Abbasi, Fady I. Malik, Christopher E. Kurtz - New England Journal of Medicine 2020 被引用: 644

  5. European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-Year Follow-Up Outcomes and Differences Across Regions

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alexandre Mebazaa - European Journal of Heart Failure 2016 被引用: 778

  6. Rosuvastatin in Older Patients with Systolic Heart Failure

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2007 被引用: 1,493

  7. Baseline Characteristics of Patients with Heart Failure with Mildly Reduced or Preserved Ejection Fraction: The FINEARTS-HF Trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alex Pui‐Wai Lee, Gerard C.M. Linssen, Guillermo Llamas-Esperón, Vyacheslav Mareev, Felipe A. Martínez, Vojtěch Melenovský, Béla Merkely, Savina Nodari, Mark C. Petrie, Clara Saldarriaga, José Francisco Kerr Saraiva, Naoki Sato, Morten Schou, Kavita Sharma, Richard W. Troughton, Jacob A. Udell, Heikki Ukkonen, Orly Vardeny, Subodh Verma, Dirk von Lewinski, Л. Г. Воронков, Mehmet Birhan Yılmaz, Shelley Zieroth, James Lay‐Flurrie, Ilse van Gameren, Flaviana Amarante, Prabhakar Viswanathan, John J.V. McMurray - European Journal of Heart Failure 2024 被引用: 62

  8. Initiation of Sacubitril/Valsartan in Haemodynamically Stabilised Heart Failure Patients in Hospital or Early After Discharge: Primary Results of the Randomised TRANSITION Study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - European Journal of Heart Failure 2019 被引用: 352

  9. Prevalence of Chronic Heart Failure in Southwestern Europe: The EPICA Study

    著者: , , , , , , - European Journal of Heart Failure 2002 被引用: 615

  10. Are Hospitalized or Ambulatory Patients with Heart Failure Treated in Accordance with European Society of Cardiology Guidelines? Evidence from 12 440 Patients of the ESC Heart Failure Long-Term Registry

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - European Journal of Heart Failure 2013 被引用: 667

  11. ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Verónica Dean, Christi Deaton, Robert Fagard, Christian Funck-Brentano, David Hasdai, Arno W. Hoes, Paulus Kirchhof, Juhani Knuuti, Philippe Kolh, Theresa McDonagh, Cyril Moulin, Bogdan A. Popescu, Željko Reiner, Udo Sechtem, Per Anton Sirnes, Michał Tendera, Adam Torbicki, Alec Vahanian, Stephan Windecker, Document Reviewers, Theresa McDonagh, Udo Sechtem, Luis Almenar Bonet, Panayiotis Avraamides, Hisham A. Ben Lamin, Michele Brignole, António Coca, Peter J. Cowburn, Henry Dargie, Perry Elliott, Frank A. Flachskampf, G. Guida, Suzanna Hardman, Bernard Iung, Béla Merkely, Christian Mueller, John N. Nanas, Olav Wendelboe Nielsen, Stein Ørn, John Parissis, Piotr Ponikowski - European Journal of Heart Failure 2012 被引用: 2,637

  12. Early discharge and home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban: an international multicentre single-arm clinical trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Peter E. Westerweel, Philipp S. Wild, Stavros Konstantinides, Mareike Lankeit, HoT-PE Investigators, Stavros Konstantinides, Rupert Bauersachs, Christoph Bode, Michael Christ, Christine Espinola-Klein, Annette Geibel, Mareike Lankeit, Michael Pfeifer, Sebastian Schellong, Philipp S. Wild, Harald Binder, Kurt Quitzau, Nadine Martin, Dorothea Becker, Stefano Barco, Irene Schmidtmann, Toni Anušić, Martin Schwaiblmair, Ursula Rauch‐Kröhnert, Martin Möckel, Johannes Brachmann, Jan Beyer‐Westendorf, Daniel Duerschmied, Sabine Blaschke, Marius M. Hoeper, Evangelos Giannitis, Klaus Empen, Rainer Schmiedel, Ulrich Hoffman, İbrahim Akın, Andreas Meyer, Sabine Genth‐Zotz, Joachim H. Ficker, Tobias Geisler, Matthias Held, Cecilia Becattini, Ludovica Anna Cimini, Jörg Herold Walter Ageno, Rodolfo Sbrojavacca, Enrico Bernardi, Giuseppe Bettoni, Roberto Cosentini, P Moscatelli, Cinzia Nitti, Maria Pazzaglia, Raffaele Pesavento, Alessandra Ascani, Francesca Cortellaro, Nicola Montano, Peter E. Westerweel, Pedro Ruiz‐Artacho, David Jiménez, Aitor Ballaz-Quincoces, Raquel López Reyes, Remedios Otero, Cândida Fonseca, Tiago Judas, Inês Araújo, Sérgio Luchini Batista, Fabienne Gonçalves, Veli‐Pekka Harjola, Pirjo Mustonen, Georgios Hahalis, Athanassios Manginas, Konstantinos Gougoulianis ほか 10 名 - European Heart Journal 2019 被引用: 154

  13. Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , E. Goncalvesova, M. Hassanein, J Hradec, A. Kavoliuniene, M Lainscak, D. Logeart, B. Merkely, Marco Metra, M. Otljanska, Petar Seferović, Elizabeta Srbinovska Kostovska, A. Temizhan, D. Tousoulis, Teresa Ferreira, Maryna Andarala, Edoardo Fiorucci, Elin Folkesson Lefrancq, Myriam Glémot, G. Gracia, Marème Konté, C Laroche, Patti-Ann McNeill, V. Missiamenou, C. Taylor, J. Auer, K. Ablasser, F.M. Fruhwald, T. Dolze, K. Brandner, S. Gstrein, G. Poelzl, D. Moertl, S. Reiter, Andrea Podczeck-Schweighofer, Adis Muslibegovic, M. Vasilj, E. Fazlibegovic, M. Cesko, D. Zelenika, Benjamin Palić, D. Pravdic, D. Cuk, Katerina Vitlianova, T. Katova, T. Velikov, T. Kurteva, P. Gatzov, D. Kamenova, M. Antova, V. Sirakova, J. Krejci, Monika Mikolášková, J. Spinar, J. Krupicka, F. Malek, M. Hegarova, M. Lazarova, Z. Monhart, M. Hassanein, M. Sobhy, F. El Messiry, A.H. El Shazly, Y. Elrakshy, Ali Ahmed Youssef, Ashraf Abdel-Hamid Abdel- Moneim, MohamedF El Noamany, Ashraf Reda, T.K. Abdel Dayem, N. Farag, S. Ibrahim Halawa ほか 553 名 - JACC Heart Failure 2018 被引用: 156

  14. Finerenone, Obesity, and Heart Failure With Mildly Reduced/Preserved Ejection Fraction

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2024 被引用: 44

  15. Effects of omecamtiv mecarbil in heart failure with reduced ejection fraction according to blood pressure: the GALACTIC-HF trial

    著者: , , , , , , , , , , , , , , , , , , , - European Heart Journal 2022 被引用: 35

  16. The patient perspective: Quality of life in advanced heart failure with frequent hospitalisations

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Robert H. G. Schwinger, Manfred Wieser, I. S. Yavelov, Robert Zymliński - International Journal of Cardiology 2015 被引用: 165

  17. Omecamtiv Mecarbil in Chronic Heart Failure with Reduced Ejection Fraction: GALACTIC-HF Baseline Characteristics and Comparison with Contemporary Clinical Trials

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Piotr Ponikowski, Félix José Alvarez Ramires, Pranas Šerpytis, Karen Sliwa, Jindřich Špinar, Thomas Suter, János Tomcsányi, Hans Vandekerckhove, Dragoş Vinereanu, Adriaan A. Voors, Mehmet Birhan Yılmaz, Faı̈ez Zannad, Lucie Sharpsten, Jason C. Legg, Siddique Abbasi, Claire Varin, Fady I. Malik, Christopher E. Kurtz, GALACTIC-HF Investigators - European Journal of Heart Failure 2020 被引用: 65

  18. Heart failure in Europe: Guideline‐directed medical therapy use and decision making in chronic and acute, pre‐existing and de novo, heart failure with reduced, mildly reduced, and preserved ejection fraction – the ESC EORP Heart Failure III Registry

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , for the ESC EORP HF III National Leaders and Investigators - European Journal of Heart Failure 2024 被引用: 50

  19. Sex Differences in Heart Failure With Reduced Ejection Fraction in the GALACTIC-HF Trial

    著者: , , , , , , , , , , , , , , , , , , - JACC Heart Failure 2023 被引用: 27

  20. Levosimendan beyond inotropy and acute heart failure: Evidence of pleiotropic effects on the heart and other organs: An expert panel position paper

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Robert H. G. Schwinger, Bojan Vrtovec, Mehmet Birhan Yılmaz, Marzenna Zielińska, John Parissis - International Journal of Cardiology 2016 被引用: 136

  21. Levosimendan Efficacy and Safety: 20 Years of SIMDAX in Clinical Use

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alexandre Mebazaa, Markku S. Nieminen, Fabrizio Oliva, Julius Gy. Papp, John Parissis, Alexander Parkhomenko, Pentti Põder, Gerhard Pölzl, Alexander Reinecke, Sven‐Erik Ricksten, Hynek Říha, Alain Rudiger, Toni Sarapohja, Robert H. G. Schwinger, Wolfgang Toller, Luigi Tritapepe, Carsten Tschöpe, Gerhard Wikström, Dirk von Lewinski, Bojan Vrtovec, Piero Pollesello - Journal of Cardiovascular Pharmacology 2020 被引用: 111

  22. Survival and quality of life after early discharge in low-risk pulmonary embolism

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sebastian Schellong, Martin Schwaiblmair, Raoul Stahrenberg, Luca Valerio, Peter E. Westerweel, Philipp S. Wild, Stavros Konstantinides - European Respiratory Journal 2020 被引用: 33

  23. Diagnosis of heart failure in primary care

    著者: - Heart Failure Reviews 2006 被引用: 111

  24. Levosimendan Efficacy and Safety: 20 years of SIMDAX in Clinical Use

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alexandre Mebazaa, Markku S. Nieminen, Fabrizio Oliva, Julius-Gyula Papp, John Parissis, Alexander Parkhomenko, Pentti Põder, Gerhard Pölzl, Alexander Reinecke, Sven‐Erik Ricksten, Hynek Říha, Alain Rudiger, Toni Sarapohja, Robert H. G. Schwinger, Wolfgang Toller, Luigi Tritapepe, Carsten Tschöpe, Gerhard Wikström, Dirk von Lewinski, Bojan Vrtovec, Piero Pollesello, Dipartimento di Anestesia e Terapie Intensive, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy, Intensive Care Unit, National Health Service, Leeds, UK, Sydäntutkimussäätiö, Helsinki, Finland, Statistical Services, R&D, Orion Pharma, Espoo, Finland, Critical Care Proprietary Products, Orion Pharma, Espoo, Finland - Cardiac failure review 2020 被引用: 67